ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Cancer.Net’s Guide to Multiple Myeloma. Use the menu to see other pages. Think of that menu as a roadmap to this full guide.
Myeloma is a blood cancer of cells found in the bone marrow, specifically the so-called “plasma cells.” The bone marrow is the spongy tissue inside your bones that normally creates the different parts of your blood. Plasma cells are a key part of the body's immune system. In particular, they produce antibodies that help the body fight infection. Myeloma begins when healthy plasma cells change and grow out of control. This may result in multiple bone lesions that increase the risk of bone fractures. That is where the phrase "multiple myeloma" comes from.
Abnormal plasma cells can crowd out or suppress the growth of other cells in the bone marrow, including red blood cells, white blood cells, and platelets. They also reduce the creation of normal plasma cells, which lowers a person’s immunity. This suppression may result in:
Anemia, from a shortage of red blood cells
Excessive bleeding from cuts to the skin, from a shortage of platelets
Decreased ability to fight infection, from a shortage of white blood cells and the body’s inability to respond to infection because of the presence of abnormal antibodies
It is important to note that, like regular plasma cells, myeloma cells can produce antibodies. But myeloma cells are unable to produce healthy, functioning antibodies. Instead, they make what is called “monoclonal protein,” "monoclonal immunoglobulin," or “M protein.” M protein can build up in the blood and urine, potentially damaging the kidneys and other organs, as well as reducing immunity. A healthy person who is found to have a small amount of this M protein is said to have monoclonal gammopathy of undetermined significance (MGUS).
Myeloma causes structural bone damage, which can result in weakened bones and leads to painful fractures or bone breaks over time. Myeloma is usually called multiple myeloma because most people (90% or more) have more than 1 bone lesions when diagnosed or lesions develop over the course of the illness.
Solitary plasmacytoma is a mass, or tumor, of myeloma cells that involves only 1 site in the bone or, less commonly, in other organs, such as those in the upper respiratory tract, including the nose and throat, or gastrointestinal systems.
Extramedullary plasmacytoma describes myeloma that started outside the bone marrow in locations such as the lymph glands, sinuses, throat, liver, digestive tract, or under the skin.
Normal Bone Marrow
Click to Enlarge
Click to Enlarge
In multiple myeloma, numerous malignant plasma cells are shown. They are characterized by a pale area within the cytoplasm, near the nucleus. Compare with normal bone marrow cells. These images used with permission by the College of American Pathologists.
Looking for More of an Introduction?
If you would like more of an introduction, explore these related items. Please note that these links will take you to other sections on Cancer.Net:
- ASCO Answers Fact Sheet: Read a 1-page fact sheet that offers an introduction to multiple myeloma. This free fact sheet is available as a PDF, so it is easy to print.
- Cancer.Net Patient Education Video: View a short video led by an ASCO expert and patient advocate that provides basic information and areas of research related to multiple myeloma.
The next section in this guide is Statistics. It helps explain how many people are diagnosed with multiple myeloma and general survival rates. Use the menu to choose another section to read in this guide.